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Building and Mining an Atlas of the Mammalian Circadian Transcriptome
Abstract
Nearly all mammals possess internal clocks that synchronize with the day-night cycles of their
environments. These circadian clocks help temporally segregate competing or incompatible physiological
processes to anticipated appropriate times of the day. As the mammalian clock system is principally
regulated by transcription factors, numerous previous studies have sought to characterize gene-transcript
oscillations as a primary means of gaining insight into what pathways are controlled by the clock.
However, most studies have only examined one or two specific tissue types at a time, often with
suboptimal sampling resolution. Little work has been done to analyze clock control at the organism level.
Furthermore, despite the apparent importance of circadian rhythms in nearly all major physiological
processes, actionable medical knowledge has been difficult to extract. This lack of translational insight is
not due to a simple lack of data, but rather to gaps in assembling a big picture from scattered data and to
deficiencies in analytical methods.
The goal of this dissertation was to overcome these shortcomings by forging a comprehensive atlas of
the mammalian circadian transcriptome. High-throughput techniques were used to identify circadian
transcript rhythms at a high sampling resolution in twelve different organs. This work brought to light
critical systemic roles of the mammalian circadian clock at the organism level, while providing a blueprint
for future advancements in chronotherapy. Findings from this work have actionable implications for the
dosing of many important drugs. An algorithm for analyzing gene-phase set enrichment was also
developed to address insufficiencies in existing methods. Applying this algorithm to earlier data
uncovered insights into the relative timing of circadian genes that were missed when using existing
methods. Further mining of data from other labs revealed unexpected findings that challenge current
paradigms in the field. Taken in sum, the work presented in this dissertation is an evaluation into how our
internal clocks schedule the myriad aspects of our physiology on a daily basis, with striking ramifications
for clinical medicine.
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ABSTRACT

BUILDING AN ATLAS OF THE MAMMALIAN CIRCADIAN TRANSCRIPTOME
Ray Zhang
John B. Hogenesch

Nearly all mammals possess internal clocks that synchronize with the day-night
cycles of their environments. These circadian clocks help temporally segregate
competing or incompatible physiological processes to anticipated appropriate times of
the day. As the mammalian clock system is principally regulated by transcription factors,
numerous previous studies have sought to characterize gene-transcript oscillations as a
primary means of gaining insight into what pathways are controlled by the clock.
However, most studies have only examined one or two specific tissue types at a time,
often with suboptimal sampling resolution. Little work has been done to analyze clock
control at the organism level. Furthermore, despite the apparent importance of circadian
rhythms in nearly all major physiological processes, actionable medical knowledge has
been difficult to extract. This lack of translational insight is not due to a simple lack of
data, but rather to gaps in assembling a big picture from scattered data and to
deficiencies in analytical methods.
The goal of this dissertation was to overcome these shortcomings by forging a
comprehensive atlas of the mammalian circadian transcriptome. High-throughput
techniques were used to identify circadian transcript rhythms at a high sampling
resolution in twelve different organs. This work brought to light critical systemic roles of
the mammalian circadian clock at the organism level, while providing a blueprint for
future advancements in chronotherapy. Findings from this work have actionable
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implications for the dosing of many important drugs. An algorithm for analyzing genephase set enrichment was also developed to address insufficiencies in existing methods.
Applying this algorithm to earlier data uncovered insights into the relative timing of
circadian genes that were missed when using existing methods. Further mining of data
from other labs revealed unexpected findings that challenge current paradigms in the
field. Taken in sum, the work presented in this dissertation is an evaluation into how our
internal clocks schedule the myriad aspects of our physiology on a daily basis, with
striking ramifications for clinical medicine.
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CHAPTER 1:
A REVIEW OF CIRCADIAN RHYTHMS

Life evolved on a rotating planet. As a consequence, biological adaptations to the
phenomenon of oscillation are some of the most fundamental and well-preserved
features of living organisms. When the development of the scientific method introduced
quantitative observations to the study of biology, circadian rhythms were one of the first
curiosities of life to receive rigorous investigation. In as early as 1729, a French
astronomer named Jean-Jacques d’Ortous de Mairan published evidence that Mimosa
plant leaves opened and closed on a 24-hour cycle, even when placed in a box of
constant darkness(Lemmer 2009). The leaves would unfurl as if the time of sunrise had
been anticipated through some form of internal clock. However, it was not until the
1950s that the term “circadian,” derived from the Greek words “circa” (approximately)
and “diem” (day), was introduced into the formal scientific literature by Franz
Halberg(HALBERG 1953), whom many consider to be the father of the field. Since that
time, research into circadian rhythms has expanded tremendously to the point of
widespread interest.
The biological circadian clock was first appreciated to be encoded by genetic
information when the Per gene was discovered in Drosophila melanogaster in
1971(Konopka & Benzer 1971). These early experiments used forward genetics to
identify genes causing a mutant phenotype wherein 24-hour rhythms of the animal were
drastically disrupted. Within the decades following, multiple studies identified other
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critical genes involved in the clock, in a numerous variety of organisms, and reported
involvement of the clock in controlling aspects of physiology such as sleep, development,
metabolism, signal transduction, and immune function. In 1990, a seminal paper by
Hardin et al.(Hardin et al. 1990) proposed a basic network model that would eventually
evolve into our canonic understanding of the molecular clock. This model involves a core
transcriptional negative-feedback loop whose kinetics are such that turnover of the loop
takes 24 hours, coinciding with the environmental cycle of day and night.

Core components of the mammalian circadian clock
It is now appreciated that the molecular circadian clock in mammals is principally
composed of two arms (Figure 1.1). The “positive” arm consists of the transcriptional
activators CLOCK (circadian locomotor output cycles kaput) and BMAL1 (brain and
muscle Arnt-like protein). These two members of the basic helix-loop-helix (bHLH)-PAS
(Period-Arnt-Single-minded) transcription factor family heterodimerize in the cytoplasm
to form a complex that can translocate to the nucleus to initiate transcription of genes in
the “negative” arm: the Period (Per1, Per2, Per3) and Cryptochrome (Cry1, Cry2)
genes(Yoo et al. 2005). The PER and CRY gene products of the negative arm are
transcriptional repressors, which also heterodimerize in the cytoplasm to form a complex
that can translocate into the nucleus. In the nucleus, PER-CRY complexes inhibit
CLOCK-BMAL1 complexes, imposing negative feedback onto the loop. As CLOCKBMAL1 complex activity decreases, formation of PER-CRY complexes halts as a
result(van der Horst et al. 1999). As PER-CRY complexes recede and are degraded,
CLOCK-BMAL1 complex activity begins again(Yu et al. 2002). This entire cycle requires
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approximately 24 hours to take place and is robust to steady-state changes in
temperature or metabolism(Takahashi et al. 2008).

Figure 1.1: The core loops of the circadian clock of mammals.
PER=Period, CRY=Cryptochrome, BMAL1=Brain and Muscle ARNT-like 1 CK1d/e=Casein
kinase 1 delta/epsilon. red arrows indicate inhibition and green ones indicate stimulation. This
image is by Nitramus and is licensed under the GNU Free Documentation License at Creative
Commons (Circadian clock of mammals.PNG). The DNA molecule is by Michael Ströck and
licensed under GFDL at Commons (DNA Overview.PNG).

The core transcription-factor loop is secondarily modulated by interactions with a
number of other associated feedback loops. The best studied of these “accessory” loops
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involves the nuclear hormone receptors REV-ERB (reverse-erb) alpha and ROR
(retinoic acid receptor-related orphan receptor) alpha/beta, which bind to enhancer
elements that repress or induce Bmal1 transcription, respectively(Preitner et al. 2002). In
turn, CLOCK-BMAL1 complexes regulate the production of REV-ERB in a similar
manner as with PER and CRY. PPAR (peroxisome proliferator-activated receptor) alpha
and its coactivator PGC1 (peroxisome proliferators-activated receptor gamma
coactivator 1) alpha further modulate this accessory loop to regulate expression of
Bmal1(Liu et al. 2007). This involvement of PPAR in the circadian clock is significant
because PPAR ligands are clinically prescribed for the control of hyperlipidemia and
hyperglycemia, especially for patients with diabetes. Evidence that disruption of
circadian rhythms is linked to metabolic disorders, one of the leading causes of morbidity
in the United States, has been increasingly brought to light(Marciano et al. 2014).
Post-transcriptional processes also play a substantial role in the regulation of the
core clock system. These processes presently make up an active area of research.
Phosphorylation of PER2 promotes dimerization with CRY(Yagita et al. 2002), while
phosphorylation of PER1 modulates nuclear translocation(Vielhaber et al. 2000).
Hyperphosphorylation of CRY by CK1 (casein kinase 1) epsilon is an important
mechanism for regulating degradation of the PER-CRY complex. Likewise, SUMOylation
of BMAL1, which occurs in a circadian rhythm, modulates degradation of the CLOCKBMAL1 complex by ubiquitination(Cardone et al. 2005).
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Hierarchy of clocks in mammals
For the mammalian circadian clock system, a distinction is made between the
“central” clock and “peripheral” clocks (Figure 1.2). The central clock is that of the
suprachiasmatic nuclei (SCN) of the hypothalamus (Figure 1.3). It is considered as the
body’s master clock, to which clocks in the rest of the body (periphery) are synchronized.
The SCN pacemaker is entrained daily by light cues from the environment that stimulate
specialized photoreceptors in the retina(Golombek & Rosenstein 2010), and, for
mammals, light is the only major stimulus capable of setting the master clock under
normal conditions.

Figure 1.2: Central and peripheral clocks.
The body has other secondary or peripheral circadian clocks, located in various organs, but all
are influenced by the central circadian clock in the suprachiasmatic nucleus. This image has been
reproduced from Science Direct(Takeda & Maemura 2010).
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In contrast, peripheral clocks, though synchronized by the central rhythm, are not
directly affected by light and actually oscillate independently of the central nervous
system. Studies have shown that peripheral tissues can maintain their own circadian
rhythms for days even after complete experimental isolation from the SCN(Yoo et al.
2004). Rather than light itself, other cues are responsible for principally resetting in
peripheral tissues, the best-known example of which is feeding(Hara et al. 2001). Due to
this discrepancy in the primary resetting stimulus between the SCN and periphery, it is
possible for central clocks to become decoupled and phase-shifted from peripheral
clocks, as has been observed in mice under conditions of restricted feed time(Damiola et
al. 2000). Mismatches in rhythm phase between tissues is likely to have deleterious
systemic effects and has been associated with diseases such as Huntington’s(Maywood
et al. 2010).
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Figure 1.3: The biological clock is located within the suprachiasmatic nucleus in the brain.
This image has been reproduced from Psychology Continuing Education(Anon n.d.).

Genome-wide circadian gene expression
Around the start of the 21st century, microarray technology heralded the ability for
large-scale observation of gene expression across an entire genome. Numerous studies
aimed at identifying the circadian transcriptome in various tissues and under different
conditions were published(Ueda et al. 2002; Panda et al. 2002; Duffield et al. 2002;
Storch et al. 2002). Multiple studies concurred that approximately 10-15% of genes in
the mammalian genome are expressed in a circadian rhythm. However, the overall
expression pattern of such genes could differ greatly between different tissues. For
example, Storch et al.(Storch et al. 2002) reported that circadian genes in the heart
tended to have peak expression at nearly the same time of the day as each other, while
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circadian genes in the liver tended to have peak expression distributed broadly
throughout the day. Furthermore, the identities of circadian genes also tended to be
quite different between tissues. Out of 650 circadian genes that were detected in the
SCN or liver by Panda et al., only 28 were found in common between both organs.
Similar findings of tissue-specificity amongst circadian genes were reported in similar
studies of other tissues. With the recent advent of high-throughput sequencing
technologies, many groups have prepared to further investigate this line of research
using RNA-sequencing instead of, or in addition to, microarrays.
Most studies of this type have held to the same methodological principles that
were used by Jean-Jacques d’Ortous de Mairan back in 1729. The subject of study,
whether it be an animal or plant, is first entrained to baseline oscillations in the
environment. In modern research, this typically means exposure to a controlled
environment with alternating 12-hours of light and 12-hours of dark, for several days,
while other environmental stimuli such as temperature, noise, and food are held constant.
The subject is then “released” into constant darkness and observed by various means.
Under constant darkness, features that are driven by the subject’s circadian clock, such
as circadian gene expression, will continue to oscillate, while those that are driven
directly in reaction to light will lose rhythmicity. Through applying genomic techniques to
this study design, researchers have sought to identify how much of the genome is
circadian.
While the canonic estimate has been that 10-15% of mammalian genes oscillate
in a circadian rhythm (Figure 1.4), this answer is not clear-cut for several reasons. Firstly,
technical aspects of microarray technology and normalization can strongly bias the data
from a statistical perspective. Secondly, collection of RNA from the subject is generally
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an invasive procedure that demands the subject to be sacrificed. Thus, each data point
from circadian gene-expression time-series have almost always come from different
individuals, which introduces additional layers of error. Thirdly, studies are often
extremely limited in the number of circadian cycles (days) that may be observed at an
acceptable temporal resolution due to cost. By the Nyquist theorem, a certain sampling
rate must be achieved in order to faithfully recover an oscillatory signal. Most studies
have used a sampling resolution of 6- or 4-hours, over two (sometimes even one) days.
Thus, most studies have been underpowered to detect circadian rhythms. Finally, the
statistical tests used to detect oscillations in gene expression have varied significantly
from study to study, ranging from goodness-of-fit based tests such as COSOPT(Nelson
et al. n.d.) and JTK_CYCLE(Hughes et al. 2010), to Fourier-based algorithms such as
Lomb-Scargle(Glynn et al. 2006) and Arser(Yang & Su 2010). These tests have been
known to yield discrepant results under different circumstances(Wu et al. 2014). Taken
altogether, the exact degree to which the mammalian genome is under circadian control,
especially at the organism level, is still not well answered.
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Figure 1.4: Example of circadian gene expression.
Gene expression profile of the Bmal1 gene, also known as Arntl, in mouse liver. X-axis units are
hours (circadian time), while y-axis units are arbitrary expression units. This plot was downloaded
from the CircaDB database (http://bioinf.itmat.upenn.edu/circa/), with data deriving from a study
by Hughes et al.(Hughes et al. 2009)

Effects of the clock on the body
The circadian clock allows an organism the ability to anticipate critical events in
their surroundings, such as sunrise, rather than merely to react to them. It allows
different structures within the body to temporally segregate competing or incompatible
processes, such as rest vs. wakefulness or synthesis vs. degradation, and furthermore
allows these processes to be synchronized to the appropriate time of day(Robertson et
al. 2008). This internal preparation has been shown to provide selection advantage in a
variety of organisms. Reproductive fitness and/or growth are noticeably worsened in
cyanobacteria(Ouyang et al. 1998), Drosophila melanogaster(Beaver et al. 2002), and
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Arabidopsis thaliana(Dodd et al. 2005) when the endogenous clock is either mutated or
made asynchronous with a 24-hour light/dark cycle.
In fact, the circadian clock seems to have a role in nearly all major aspects of
physiology, including sleep, feeding, growth, movement, hormone secretion, and
immune function(Sharma 2003)(Figure 1.5). Disruption of an animal’s normal circadian
rhythms affects glucose homeostasis, lipid metabolism, cardiovascular disease, and
chemotherapeutic sensitivity(Martino et al. 2008; Scheer et al. 2009; Buxton et al. 2012).
Mutations in genes controlling the circadian clock result in increased sensitivity to
mutagens(Fu et al. 2002; Hoffman et al. 2010), while alterations in cell cycle checkpoints
precede cancer(Kastan & Bartek 2004). Shift work is epidemiologically linked to
increased risk of obesity(De Bacquer et al. 2009), diabetes(Maury et al. 2010),
cardiovascular disease(Faraut et al. 2012), and cancers of the breast(Davis et al. 2001;
Grundy et al. 2013), prostate(Flynn-Evans et al. 2013), endometrium(Viswanathan et al.
2007), and other organs(Sahar & Sassone-Corsi 2009; Parent et al. 2012). The history
of our evolution has been so fundamentally dependent on the perpetual cycle of day and
night that one might jest, not inaccurately, circadian rhythms are “in our bones.”
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Figure 1.5: Biological clock affects the daily rhythm of many physiological processes.
This diagram depicts the circadian patterns typical of someone who rises early in morning, eats
lunch around noon, and sleeps at night (10 p.m.). Although circadian rhythms tend to be
synchronized with cycles of light and dark, other factors - such as ambient temperature, meal
times, stress and exercise - can influence the timing as well. The work was done with Inkscape by
YassineMrabet. Informations were provided from "The Body Clock Guide to Better Health" by
Michael Smolensky and Lynne Lamberg; Henry Holt and Company, Publishers (2000).
Landscape was sampled from Open Clip Art Library (Ryan, Public domain). Vitruvian Man and
the clock were sampled from Image:P human body.svg (GNU licence) and Image:Nuvola apps
clock.png, respectively. This image is licensed under the GNU Free Documentation License at
Creative Commons.

There is growing pharmaceutical interest in leveraging circadian rhythms to
improve treatment – a concept referred to as “chronotherapy.” Studies have found that
the time at which a drug is dosed can significantly influence the efficacy and side-effect
12	
  
	
  

profile of treatment(Baraldo 2008). A notable example is seen in the treatment of
hypertension(Hermida et al. 2007), as blood pressure has long been known to rise
during the day and decline during the night. Other examples include the treatment of
asthma(Pincus et al. 1995), and the use of non-steroidal anti-inflammatory drugs
(NSAIDS)(Levi & Schibler 2007) and statins(Mück et al. 2000), which have all been
found to work better at certain times of the day. Chemotherapy has been suggested to
be more tolerable for patients whose circadian rhythms are properly maintained after
treatment(Ortiz-Tudela et al. 2014). Despite these findings, however, circadian rhythms
are generally not yet part of any primary consideration in the clinical setting for most
other situations as translatable research on this topic is still in its infancy. A full
understanding of the clock at the systems level will likely have a tremendous impact on
our ability to improve health.

Goals of this dissertation
Nearly all mammals possess internal clocks that synchronize with the day-night
cycles of their environments. These circadian clocks help temporally segregate
competing or incompatible physiological processes to anticipated appropriate times of
the day. As the mammalian clock system is principally regulated by transcription factors,
numerous previous studies have sought to characterize gene-transcript oscillations as a
primary means of gaining insight into what pathways are controlled by the clock.
However, most studies have only examined one or two specific tissue types at a time,
often with suboptimal sampling resolution. Little work has been done to analyze clock
control at the organism level. Furthermore, despite the apparent importance of circadian
rhythms in nearly all major physiological processes, actionable medical knowledge has
13	
  
	
  

been difficult to extract. This lack of translational insight is not due to a simple lack of
data, but rather to gaps in assembling a big picture from scattered data and to
deficiencies in analytical methods.
The goal of this dissertation was to overcome these shortcomings by forging a
comprehensive atlas of the mammalian circadian transcriptome. High-throughput
techniques were used to identify circadian transcript rhythms at a high sampling
resolution in twelve different organs. This work brought to light critical systemic roles of
the mammalian circadian clock at the organism level, while providing a blueprint for
future advancements in chronotherapy. Findings from this work have actionable
implications for the dosing of many important drugs. An algorithm for analyzing genephase set enrichment was also developed to address insufficiencies in existing methods.
Applying this algorithm to earlier data uncovered insights into the relative timing of
circadian genes that were missed when using existing methods. Further mining of data
from other labs revealed unexpected findings that challenge current paradigms in the
field. Taken in sum, the work presented in this dissertation is an evaluation into how our
internal clocks schedule the myriad aspects of our physiology on a daily basis, with
striking ramifications for clinical medicine.
The overarching focus of this work has been to lay a foundation for extracting
knowledge about circadian rhythms that will be directly impactful in changing the
landscape of medicine. My hope is that the findings herein can stimulate an eventual
shift in clinical paradigms towards a more serious consideration of circadian time during
the diagnosis and treatment of diseases in real-world patients.
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CHAPTER 2:
A CIRCADIAN GENE EXPRESSION ATLAS IN MAMMALS

Circadian rhythms are endogenous 24-hour oscillations in behavior and
biological processes found in all kingdoms of life. This internal clock allows an organism
to adapt its physiology in anticipation of transitions between night and day. The circadian
clock drives oscillations in a diverse set of biological processes, including sleep,
locomotor activity, blood pressure, body temperature, and blood hormone levels(Levi &
Schibler 2007; Curtis & Fitzgerald 2006). Disruption of normal circadian rhythms leads to
clinically relevant disorders including neurodegeneration and metabolic
disorders(Hastings & Goedert 2013; Marcheva et al. 2010). In mammals, the molecular
basis for these physiological rhythms arises from the interactions between two
transcriptional/translational feedback loops (reviewed in(Lowrey & Takahashi 2011)).
Many members of the core clock regulate the expression of other transcripts. These
clock-controlled genes mediate the molecular clock’s effect on downstream rhythms in
physiology.
In an effort to map these connections between the core clock and the diverse
biological processes it regulates, researchers have devoted significant time and effort to
studying transcriptional rhythms (Panda et al. 2002; Storch et al. 2002; Hughes et al.
2009; Koike et al. 2012; Vollmers et al. 2012). While extremely informative, most
circadian studies of this nature have analyzed one or two organs using microarrays, and
little work has been done to analyze either clock control at the organism level or
15	
  
	
  
	
  

regulation of the non-coding transcriptome. To address these gaps in our knowledge, we
used RNA-sequencing (RNA-seq) and DNA arrays to profile the transcriptomes of twelve
different mouse organs: adrenal gland, aorta, brainstem, brown fat, cerebellum, heart,
hypothalamus, kidney, liver, lung, skeletal muscle, and white fat. We sampled organs
every 6 hours by RNA-seq and every 2 hours by arrays, to develop an atlas of mouse
biological space and time.
Using this resource, we examined the genomic characteristics of the rhythmic
coding and non-coding transcriptomes, the differences between organs in timing (phase)
and identity of oscillating transcripts, and the functional implications of rhythmic
regulation in various biological pathways. Lastly, we explored the potential medical
impact of circadian genes as drug targets and disease-associated genes. It is our hope
that this work provides a rich dataset to the research community that could power many
future studies.

Genes and non-coding transcripts
We defined a background set of 19,788 known protein-coding mouse genes and
for each organ we used the JTK_CYCLE(Hughes et al. 2010) algorithm to detect 24hour oscillations in transcript abundance. For this protein-coding gene analysis, we
leveraged the high temporal resolution of the array data to accurately identify circadian
genes. We set a 5% false-discovery-rate for detection, though the specific value of this
cutoff did not affect the relative amount of rhythmic transcripts detected between organs
(Figure 2.1A). In this context, we defined the term “circadian gene” as any gene
identified as cycling with a 24-hour period by JTK_CYCLE, and passing the FDR cutoff
listed above. We used the base-pair level RNA-seq data in a complimentary fashion to
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identify the expressed spliceforms of these circadian genes, and for our analysis of the
non-coding transcriptome.

Figure 2.1: Identifying oscillating transcripts across different organs.
A) The number of oscillating transcripts identified in each tissue as a function of the JTK_CYCLE
significance cutoff. B) The average total number of oscillating genes detected as a function of the
number of organs sampled. This is a repetition of the calculation performed in Figure 2.2C, using
only data from organs with a more homogeneous composition (liver, kidney, lung, heart, adrenal
gland, and skeletal muscle). Error bars represent standard deviation. Best-fit model has been
overlayed in red. C) Radial diagrams showing the phase distribution of oscillating genes in each
organ. These are enlarged versions of those included down the right side of Figure 2.5A.
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Following these analyses, we found liver had the most circadian genes (3,186),
while hypothalamus had the fewest (642) (Figure 2.2A). In fact, the three brain regions
(cerebellum, brainstem and hypothalamus) had the fewest circadian genes, collectively.
Due to the technical difficulty of precisely sampling brain regions, we assume that
heterogeneous mixtures of cell types within these complex organs may express different
sets of genes, or may be out of phase with each other. This transcript/phasediscrepancy within the same organ would make it difficult to accurately identify circadian
genes in these brain regions. On average, 46% (s.d.=0.036%) of circadian proteincoding genes expressed multiple spliceforms detected in the RNA-seq data.

Figure 2.2. Breakdown of circadian genes and ncRNAs.
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A) Number of protein-coding genes in each organ with circadian expression. Blue marks indicate
the number of genes with at least 1 spliceform detected by RNA-seq. Orange marks indicate the
number of genes with at least 2 spliceforms detected by RNA-seq. Blue numbers to the right of
each bar list the percentage of protein-coding genes which rhythmic expression in each organ. B)
Distribution of the number of organs in which a protein-coding gene oscillated. C) Average total
number of circadian genes detected as a function of the number of organs sampled. Error bars
represent standard deviation. Best-fit model has been overlayed in red. D) Percentages of each
transcript class that did vs. did-not oscillate in at least one organ.

Transcript abundance for 43% of protein-coding genes oscillated in at least one
organ (Figure 2.2B). Only ten genes oscillated in all organs: Arntl, Dbp, Nr1d1, Nr1d2,
Per1, Per2 and Per3 (core clock factors), as well as Usp2, Tsc22d3, and Tspan4. While
the organs we analyzed provide a broad sampling across the entire organism, there are
still many more to study which may contain additional circadian genes. The average
number of total circadian genes, y, detected by randomly sampling x organs was closely
modeled by the exponential function y=a(1-e-bx), where e is Euler’s number and the
coefficients a (asymptote) and b (rate of asymptotic approach) equal 10,901 and 0.123,
respectively (R2>0.99; Figure 2.2C). This estimate remains unchanged if we exclude the
potentially noisy, heterogeneous organs discussed above (Figure 2.3B). In other words,
as we continue to sample additional organs, we predict ~10,901 mouse protein-coding
genes (55% of the background set) will show circadian oscillations somewhere in the
body.
To study the non-coding transcriptome, we used the NONCODE to define a
background set of 1,016 mouse-human conserved ncRNAs (Figure 2.3A;
Supplementary Methods). We found 32% of conserved ncRNAs oscillated (a similar
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proportion compared to protein-coding genes), while non-conserved ncRNAs were less
likely to oscillate (Figure 2.2D). This suggests our set of conserved ncRNAs may be
functionally relevant. Unlike protein-coding genes, no individual ncRNA oscillated in
more than five organs. This is unsurprising, given that ncRNA expression is known to be
organ-specific(Washietl et al. 2014). We also found 712 of 5,154 unannotated, spliced
non-coding transcripts (Supplementary Methods) had rhythmic expression. 80% of these
aligned to the human genome (BLASTN, E<10-10, sequence identity >70%), indicating
they are conserved between human and mouse.

Figure 2.3: Conserved circadian ncRNAS.
(A) Method overview for identifying conserved ncRNAs. Full details on this method are available
in the main text of the paper and in the Supplementary Methods. (B) Functional types of circadian
conserved ncRNAs. Types were defined by GENCODE and Ensembl biotypes, assigned by using
Ensembl and manual annotation.

These conserved, clock-regulated ncRNAs covered a diverse set of functional
classes (Figure 2.3B). We found 30 were antisense to protein-coding genes, half of
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which were themselves circadian. There was no general phase relationship between
sense and antisense ncRNAs. For example, in the liver, both Galt (galactose-1phosphate uridylyltransferase) and an overlapping antisense ncRNA oscillated in phase
with each other (Figure 2.4A-D). We also identified host genes for 39 circadian miRNAs
and four snoRNA host genes: Cbwd1, Snhg7, Snhg11, and Snhg12. As snoRNAs were
recently shown to have light-driven oscillations in Drosophila brains(Hughes et al. 2012),
these findings provide further evidence of the clock's potential to influence ribosome
biogenesis(Jouffe et al. 2013). We also found 74 conserved lincRNAs with circadian
oscillations, the majority of which were Riken transcripts with no known function. Finally,
we also found 1979 genes with un-annotated antisense transcripts, 187 of which showed
sense and antisense oscillations in the same organ. Of these, 43 antisense transcripts
oscillated at least eight hours out of phase with their sense transcripts. Genes with antiphase, antisense oscillators included Arntl and Per2 (Figure 2.4E-H). A known Per2
antisense transcript (Koike et al. 2012; Vollmers et al. 2012) oscillated in 4 organs, the
most of any antisense transcript, providing further evidence of its functional relevance.
Taken together, our data reflect a vast and diverse set of transcripts regulated by the
clock at the organism level.
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Figure 2.4: Representative examples of conserved circadian ncRNAs and anti-sense transcripts.
A) RNA-seq coverage plot for Galt (red) and its antisense transcript (blue). The gene model for
Galt is displayed above the coverage plots. B) Expression profiles for Galt (red; data from
microarrays) and the antisense transcripts (blue; data from RNA-seq). Gray regions indicate
subjective night. C) RNA-seq coverage plot for Snhg12. The gene model is displayed below the
coverage plot. Note the locations of the mature snoRNA sequences located in the introns of
Snhg12. D) RNA-seq expression profiles for Snhg12 in brown adipose and hypothalamus. E)
RNA-seq coverage plot for Arntl (red) and its antisense transcript (blue), from white adipose. The
gene model for Arntl is displayed above the coverage plots. F) Expression profiles for Arntl (red;
data from microarrays) and the antisense transcripts (blue; data from RNA-seq), from white
adipose and liver. G) RNA-seq coverage plot for Per2 (red) and its antisense transcript (blue),
from white adipose. The gene model for Per2 is displayed above the coverage plots. H)
Expression profiles for Per2 (red) and the antisense transcript (blue) from liver, adrenal gland,
lung, and kidney.
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Gene parameters
Our data agree with the finding from previous multi-organ studies that the vast
majority of circadian-gene expression is organ-specific (Storch et al. 2002; Panda et al.
2002), with little overlap of circadian-gene identity between organs (Figure 2.5A). In most
organs, expression of circadian genes peaked in the hours preceding subjective dusk or
dawn, often in a bi-modal fashion. Heart and lung were notable exceptions, with phase
distributions that diverged substantially from other organs. Moreover, those circadian
genes expression peaks clustered around subjective dusk or dawn also tended to have
the highest average oscillation amplitude, compared to genes with expression peaks at
other times of day. Taken together, these data suggest that the body may experience
daily “rush hours” of transcription at these critical times. Using the average phase
difference between any two organs’ shared circadian genes as a distance metric, we
were able to construct an ontogenic tree that recovered recognizable organ lineage
(Figure 2.5B)(Edgar et al. 2013). Thus, developmentally related organs tended to share
genes that oscillate synchronously.
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Figure 2.5: Parameters of circadian genes across organs.
A) Relationships between organ, oscillation amplitude and oscillation phase of circadian genes.
Upper-left quadrant: histograms of amplitudes within each organ (number of circadian genes
within each amplitude bin is shown on the horizontal axis, grouped by organ). Upper-right
quadrant: histograms of amplitudes within each phase, across all organs. Lower-right quadrant:
histograms of phases within each organ, with summary radial diagrams (number of circadian
genes within each phase bin is shown on the vertical axis, grouped by organ). Larger versions of
these radial diagrams are included in Figure 2.1C for clarity. Lower-left quadrant: Venn diagrams
of the identities of the genes that oscillated within a given pair of organs. B) Ontogenic tree
constructed using the average phase differences between each organ pair’s shared circadian
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genes as the distance metric. Shared genes correspond to the overlapping regions from Venn
diagrams in panel A.

Having examined their oscillation patterns, we looked for genomic characteristics
common to rhythmically-expressed genes. Circadian genes clustered physically in the
genome (Figure 2.6A; Supplemental Methods). Their lengths tended to be longer than
non-rhythmic genes (Mann-Whitney U test p≪10-15; Figure 2.6B). This trend was
maintained at the level of 5’UTR, CDS, and 3’UTR (Figure 2.6C-E). These results are in
agreement with previous findings about oscillating liver transcripts(Wu et al. 2012). By
using gapped, junction-spanning reads to discriminate between expressed spliceforms,
we found circadian genes had more spliceforms than non-circadian genes (MannWhitney U test p≪10-15; Figure 2.6F-H). Furthermore, we found that the spliceforms
expressed by circadian genes, including the identity of the dominant spliceform, tended
to differ across organs more than for non-circadian genes. These findings are consistent
with the idea that the circadian genes have more regulatory capacity than non-circadian
genes.
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Figure 2.6: Genomic characteristics of circadian genes.
A) Genomic clustering of each organ’s oscillatory genes. The test-statistic used was the sum of
the squared number of oscillatory genes within a sliding nine-gene window (intergenic distance
disregarded). Significance values were derived using null distributions determined by randomly
shuffling gene positions 1-million times for each organ-chromosome pair. B) Total length of
circadian vs. non-circadian genes. Length of circadian vs. non-circadian genes across C) 5ʹUTRs,
D) coding sequence, and E) 3ʹUTRs. Spliceforms counts of circadian vs. non-circadian genes for
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F) detected spliceforms, G) unique sets of spliceforms expressed across organs, and H) unique,
dominant spliceforms expressed across organs. I) Number of genes having the given maximum
phase difference between any two organs. Vegfa is shown as an example.

Remarkably, 1,400 genes were phase-shifted with respect to themselves by at
least six hours between two organs, with 131 genes completely anti-phased (Figure 2.6I).
For example, at dusk, the transcript levels of Vegfa (vascular endothelial growth factor)
peaked in brown fat but reached a nadir in heart. To our knowledge, such drastic phasediscrepancies of individual genes between organs have not been reported. The
mechanisms for these phenomena are unclear, as the genes did not share any obvious
transcription-factor or miRNA-binding motifs. The core clock genes oscillated
synchronously, with the peak phases of a given gene falling within 3 hours of each other
across all organs (Figure 2.7). Several core clock genes did show 1-2 hour phase
advances and delays in skeletal muscle and cerebellum, respectively, when compared
to other organs. However, these cases were in the minority, and given the limitations in
our ability to precisely resolve small (< 2 hour) phase differences from data with a 2-hour
resolution, their significance remains unclear. This finding indicates that the anti-phased
patterns observed in genes like Vegfa are not due to phase-differences between the
core clocks of each organ. Rather, these phenomena are due to additional, organspecific levels of timing regulation positioned between the core clock and these output
genes.
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Figure 2.7: Expression of core circadian oscillator genes across organs.
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A) Expression of each gene in all organs superimposed. B) Heatmap representation of
expression from panel A.

Pathways
Given the high temporal and spatial resolution of our study, we were able to
examine ways in which time and space influenced biological pathways. We used the
Reactome(Matthews et al. 2009) database as a basis for our pathway network and
found many pathways enriched for circadian genes both within and across organs
(Figure 2.8).

Figure 2.8: Discovering oscillation influence on pathways.
Nodes represent Reactome pathways, with size corresponding to total number of genes in a
pathway and color corresponding to percent of genes with rhythmic expression at the organism
level. Edges convey pathway hierarchy. Heatmap depicts significance of pathways’ oscillatory
fractions by Fisher’s exact test at the organ level. Network displayed in the left-most figure is
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available as a Cytoscape file
(http://itmat.nick.s3.amazonaws.com/BHTC/circadian_oscillations_in_reactome_pathways.cys).

Several genes oscillated synchronously across all organs, like the core clock
genes. For example, Dtx4, a Notch pathway E3 ubiquitin ligase, oscillated in phase with
Arntl in all organs (Figure 2.9A). We also noted that genes with “opposite” functions (e.g.,
activators vs. repressors) often had opposite phases. For example, members of the
initial vascular endothelial growth factor (VEGF) signaling cascade oscillated in the heart
(Figure 2.9B). These included the primary circulating ligand, Vegfa, and its two principle
membrane-bound receptors, Flt1 and Kdr. This cascade regulates angiogenesis, with
critical roles in development, cancer and diabetes(Folkman 2007). At dusk, expression
of Vegfa and Kdr in the heart was low, while Flt1 was high. KDR is thought to mediate
most of the known cellular responses to VEGF-signaling, while FLT1 is thought to be a
decoy receptor (Zygmunt et al. 2011). Thus, the rhythmic timing of these receptors
appears to reflect function, in that FLT1 (the decoy) is present when KDR is not and vice
versa.
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Figure 2.9: Exploring pathways across biological space and time.
A) Expression of the deltex gene Dtx4 in all organs superimposed. B) Example of pathway
components’ timing reflecting function: expression profiles from the heart, for Vegfa and its two
receptors Kdr and Flt1. Black arrows highlight times at which Flt1 and Kdr are anti-phased. C)
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Example of systemic pathway orchestration segregating in time and space: expression profile of
Igf1 in the liver, as compared to its downstream target Pik3 in several organs. D) Example of
widespread pathway component synchronization within the same space (organ): expression
profiles from the kidney for multiple signaling receptors that activate the PIK3-AKT-MTOR
pathway.

While members of some systemic pathways, such as the core circadian clock,
were expressed in phase across organs, many were not. For instance, expression of the
insulin-like growth factor Igf1 oscillated in the liver, peaking in the early subjective night
(Figure 2.9C). Since the liver produces nearly all of the circulating IGF1(Sjögren et al.
1999), IGF-signaling throughout the entire body is likely under clock influence. IGF1 is
one of the most potent natural activators of the PIK3-AKT-MTOR pathway, which
stimulates growth, inhibits apoptosis, and has a well-known role in cancer(Franke 2008).
However, peak expression of Pik3r1, which encodes the regulatory subunit for PIK3, did
not occur at the same time across all organs. Instead, there was a steady progression
throughout the night spanning nearly ten hours, as it peaked first in liver, then heart,
followed by aorta, lung, skeletal muscle, and finally in kidney (Figure 2.9C). Since the
core clocks of these organs were in phase with each other, as mentioned earlier, the
timing differences of Pik3r1 are most likely driven by some unknown, organ-specific
mechanism situated between the core clock pathway and Pik3r1.
Some pathways known to function systemically were only rhythmic in a single
organ. For example, IGF1’s principal membrane-bound receptor, IGF1R, is present in
numerous organs. However, Igf1r expression oscillated only in kidney. In addition to
Igf1r, many other membrane-bound receptors that activate the PIK3-AKT-MTOR
cascade were also rhythmically expressed only in kidney (Figure 2.9D). These included
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Erbb2, Erbb3, and Erbb4 (tyrosine kinase receptors), Tlr2 (toll-like receptor), Cd19
(antigen receptor), and Il7r (cytokine/interleukin receptor). These receptors were all
notably in phase with one another, all having peak expression in the subjective mid-day.
Thus, there is kidney-specific clock regulation of PIK3-AKT-MTOR signaling, that is
distinct from and in addition to the already clock-regulated IGF1 signal coming from the
liver.

Drug targets and disease

Rank
2
5
11
20
27
32
33
37
38
44
45
47
48
49
54
56
62

Sales
$1.46 b

Trade
name
Nexium

Indications

Circadian-gene targets

Gastritis, GERD,
Atp4a
Esophagitis
$1.28 b Advair Asthma, Chronic
Serpina6, Pgr, Nr3c2,
Diskus obstructive pulmonary di... Adrb2, Pla2g4a
$794 m Rituxan Rheumatoid arthritis, Non- Fcgr2b, Ms4a1, Fcgr3
Hodgkin's lymp...
$538 m Diovan Hypertension, Heart failure Slc22a6, Agtr1a, Slco1b2,
Car4, Kcnma...
$431 m Vyvanse Attention deficit
Adra1b
hyperactivity disorder
$392 m Tamiflu Influenza
Neu2, Neu1, Ces1g,
Slc22a8, Slc15a1, ...
$383 m Ritalin Attention deficit
Slc6a4
hyperactivity disorder
$348 m AndroGel Hypogonadism
Slc22a4, Slc22a3, Ar,
Cyp1a1, Cyp2b10...
$346 m Lidoderm Pain
Slc22a5, Cyp2b10, Egfr,
Abcb1a
$304 m Seroquel Bipolar disorder, Major
Htr2c, Htr1b, Htr2a, Chrm2,
XR
depressive disor...
Drd4, Adr...
$289 m Viagra Erectile dysfunction
Cyp1a1, Pde6g, Abcc5,
Abcc10, Pde5a, ...
$281 m Niaspan Hyperlipidemia
Slco2b1, Slc22a5, Qprt,
Slc16a1
$279 m Humalog Diabetes mellitus T2
Igf1r
$274 m Alimta Mesothelioma, Non-small Tyms, Atic, Gart, Slc29a1
cell lung cancer
$267 m Combivent Asthma, Chronic
Slc22a5, Slc22a4, Chrm2,
obstructive pulmonary di... Adrb1, Adrb2
$262 m ProAir HFA Asthma, Chronic
Adrb1, Adrb2
obstructive pulmonary di...
$240 m Janumet Diabetes mellitus T2
Slc47a1, Slc22a2, Prkab1,
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Organs in which
targets oscillate
L
Lu, H, L, K, S, A
L, K, S
H, AG, L, K, S
L
Lu, L, BF, K, C
AG, K
Lu, H, BS, WF, AG...
Lu, H, AG, BF, L,...
Lu, H, BS, WF, AG...
Lu, H, BS, WF, AG...
Lu, H, BS, AG, WF...
K
Lu, H, BS, BF, L,...
Lu, H, BS, BF, K,...
Lu, K, S
H, BS, AG, Hy, L,...

66
71
78
90
98
99

Abcb1a, Dpp4
$236 m Toprol XL Hypertension, Heart failure Slc22a2, Adrb1, Adrb2,
Abcb1a
$220 m Vytorin Hyperlipidemia
Hmgcr, Cyp2b10, Soat1,
Abcc2, Anpep, ...
$209 m Aciphex Gastritis, GERD,
Cyp1a1, Atp4a, Abcg2
Esophagitis
$189 m Lunesta Insomnia
Ptgs1, Tspo, Gabra3
$173 m Prilosec Gastritis, GERD,
Cyp1a1, Atp4a, Abcg2,
Esophagitis
Cyp1b1, Abcb1a
$171 m Focalin XR Attention deficit
Slc6a4
hyperactivity disorder

Lu, H, AG, BF, L,...
Lu, H, BS, AG, BF...
Lu, H, BS, WF, L,...
Lu, H, AG, K
Lu, H, BS, WF, AG...
AG, K

Table 2.1: Drugs of the top-100 best-seller list that target circadian genes and have half-life < 6h.
Rank and sales are based on USA 2013 Q1 data from Drugs.com. Abbreviations: AG (adrenal
gland), A (aorta), BF (brown fat), BS (brainstem), C (cerebellum), H (heart), Hy (hypothalamus), K
(kidney), L (liver), Lu (lung), S (skeletal muscle), WF (white fat).

Timing is an important but under-appreciated factor in drug efficacy. For example,
short half-life statins work best when taken before bedtime, as cholesterol synthesis
peaks when we sleep(Miettinen 1982). To find new opportunities for prospective
chronotherapy, we investigated which of the best-selling and commonly taken drugs
target genes with rhythmic expression (association between circadian genes and drug
targets by Pearson's Chi-square test, p<<10-15; Figure 2.10A). By ‘drug targets’, we are
referring to genes with products directly bound and functionally affected by a given drug.
Notably, 56 of the top 100 best-selling drugs in the United States, including all top 7,
target the product of a circadian gene (Dataset S1). Nearly half of these drugs have halflives less than 6 hours (Table 2.1), suggesting the potential impact time-of-administration
could have on their action. Most of these drugs have not been associated with circadian
rhythms and are not dosed with consideration for body time. Furthermore, 119 of the
World Health Organization’s list of essential medicines target a circadian gene, including
many of the most common and well known targets (Dataset S2). For example, Ptgs1
(cyclooxygenase-1, alias Cox1), the primary target of low dose aspirin therapy used in
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secondary prevention of heart attacks(Antithrombotic Trialists’ Collaboration 2002),
oscillated in the heart, lung, and kidney (Figure 2.10B). Given that aspirin has a short
half-life and that heart attacks have a circadian rhythm(Curtis & Fitzgerald 2006), dosing
aspirin at an optimal time of the day has great potential. Consistent with this observation,
clinical reports have suggested night-time administration of low dose aspirin may be
important for its cardio-protective effects(Hermida et al. 2005). Our data suggest a
mechanism for Ptgs1’s circadian regulation as well. Mir22 is a micro-RNA predicted to
target PTGS1, and its host transcript oscillated anti-phase to Ptgs1 in the heart, lung,
and kidney. This miRNA may therefore regulate Ptgs1 function. To test this hypothesis,
we transfected mir22 mimics into NIH3T3 cells and knocked down endogenous
quantities of PTGS1 protein by ~50% (Figure 2.11). We also observed a slight, nonsignificant decrease in Ptgs1 mRNA levels in these same samples. These data suggest
that mir22 operates on PTGS1 predominantly at the post-transcriptional level, though it
remains possible that Ptgs1 is a transcriptional target of the clock through other
mechanisms.
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Figure 2.10: Circadian disease genes and drug targets.
A) Overlap between circadian genes, known disease-associated genes, and drug targets.
Sources for disease genes and drug targets are included in the Supplemental Materials. B)
Example of a common drug having an oscillatory gene target: expression profiles for the aspirin
target Ptgs1 from heart, lung and kidney. Traces from these organs for the mir22 host gene,
predicted to target Ptgs1, are also shown. C) Number of PubMed references for circadian vs.
non-circadian genes.

Figure 2.11: Mir22 reduces endogenous PTGS1 in NIH3T3 cells.
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A) Representative Western blot analysis of lysates from NIH3T3 cells transfected with mirNeg,
mir-22-3p, or mir-22-5p. * indicates non-specific bands. B) Densitometric quantification of PTGS1
protein expression from Western blots, normalized to GAPDH protein expression. Values are
mean intensities relative to the mirNeg condition, ± SD. C) Quantification of Ptgs1 mRNA by
qPCR from the same samples assayed in B). Expression values were normalized by Gapdh, and
presented as mean abundance relative to mirNeg condition, ± SD. n = 3 for B) and C). n.s.=not
significant; *=P<0.0001, relative to mirNeg by one-sided, homoscedastic Student’s t-test.

Beyond drug targets, circadian genes were also enriched among diseaseassociated genes (Pearson’s Chi-square test, p<<10-15; Figure 2.10A), and were highly
studied in biomedical research. They received significantly more PubMed citations than
non-oscillating genes (Mann-Whitney U test, p<<10-15; Figure 2.10C). Furthermore,
oscillating genes were also associated with nearly every major disease funded by
National Institutes of Health at significantly higher rates than expected by chance (Figure
2.12). Cancer, diabetes mellitus type 2, Alzheimer’s disease, schizophrenia, Down’s
syndrome, obesity, and coronary artery disease were most strongly associated with
circadian genes. For example, many of these oscillating genes are involved in
neurodegeneration, including Fus, Tdp43, alpha synuclein, gamma synuclein, Atxn1,
Atxn2, Atxn3, Atxn7, Atxn10, Psen1, and Psen2. These genes are mutated in
frontotemporal dementia, ALS, Parkinson’s disease, spinocerebellar ataxia, and
Alzheimer’s disease. They were predominantly rhythmic outside of the brain in
peripheral organs (Psen2 had nearly four-fold amplitude in liver and peaked at subjective
day, when mice are going to sleep). We speculate that promoters for these genes may
have evolved sensitivity to global changes in redox state, which varies between day and
night(Musiek et al. 2013). Lending credence to the association between clocks and
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neurodegeneration are two clinical observations: many patients with neurodegenerationlinked dementia display ‘sundowning’ (behavioral problems in the early evening), and
most patients with neurodegeneration eventually develop circadian sleep
disorders(Hastings & Goedert 2013).

Figure 2.12: Correlation between association significance of diseases with circadian genes and
NIH research funding towards each disease.
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Discussion
In this study we used RNA sequencing and DNA microarrays to characterize
circadian oscillations in transcript expression across twelve mouse organs. We found
that the RNA abundance of 43% of mouse protein-coding genes cycle in at least one
organ. Based on these results, we project that over half of the mouse protein-coding
genome is rhythmic somewhere in the body. This is similar to the proportion of liver
genes encoding proteins detected by mass spectrometry, that also showed
transcriptional rhythms(Mauvoisin et al. 2014). There is precedence for such large-scale
rhythms in unicellular and plant studies(Liu et al. 1995; Michael & McClung 2003), and
previous work has suggested the same may be true in the mammalian system(Ptitsyn &
Gimble 2011). We found the majority of these transcriptional rhythms are organ-specific.
This characteristic, in addition to our high sampling resolution, explains why we found
more rhythmic genes across twelve organs than previous studies (including those from
our lab) that focused on only a few organs. Furthermore, the organ-specificity of these
transcriptional rhythms indicates that while the molecular clock is active throughout the
body, it regulates biological processes quite differently in each organ. Again, this is in
agreement with existing literature(Panda et al. 2002; Storch et al. 2002).
The major exception to this finding is the set of core clock genes, as these genes
oscillated in phase across all twelve organs (Figure 2.7). This is not to say that external
cues such as restricted feeding or jet-lag cannot phase-shift these peripheral oscillators
with respect to one another(Stokkan et al. 2001; Vosko et al. 2010). Rather, this agrees
with the notion that peripheral clocks are largely synchronized in a healthy organism.
Taken as a whole, our data can be used to address questions about the regulatory
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mechanisms for clock-controlled genes and these analyses are the subject of ongoing
work.
Additionally, we found a functionally diverse set of ncRNAs with rhythmic
expression. Those ncRNAs conserved between human and mouse oscillated in the
same proportion as protein-coding genes, suggesting their functional importance. While
some of these rhythmic ncRNAs have recognized functions, like snoRNA and miRNA
host genes, little is known about the majority. The oscillations of these ncRNAs may
prove advantageous for functional studies, e.g. linking a cycling miRNA to its predicted
target genes by comparing their cycles.
Recent studies have found additional layers of complexity in hepatic rhythms by
examining DNA binding patterns of core clock genes, changes in epigenetic marks, as
well as oscillations in the proteome (Koike et al. 2012; Vollmers et al. 2012; Mauvoisin et
al. 2014; Robles et al. 2014). By providing a window into every stage of the
transcriptional/translational oscillations in the liver (open chromatin, transcription factor
binding, transcription, protein accumulation), one could use these complementary
datasets to model how the interplay between DNA, RNA, and protein results in rhythmic
output in liver biology. However, these proteomic and chromatin-immunoprecipitation
assays are still quite challenging to perform, especially for organs with more limited
material than the liver. By applying the model developed in liver to our data, one could
make organism-level predictions about the rhythmic characteristics of epigenetic marks
and proteins.
The field of chronotherapeutics has appreciated the system-level effects of
circadian biology for quite some time. At its core, this field aims to understand how time
of day influences the metabolism, efficacy, toxicity, and off-target effects of
therapeutics(Levi & Schibler 2007). Consider the case of statins (reviewed in (Schachter
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2005)), a class of drug that lowers cholesterol by inhibiting HMGCR (HMG-CoA
reductase). HMGCR is the rate-limiting enzyme in cholesterol biosynthesis and its
activity peaks during the night. Statins with short half-lives showed maximal efficacy
when taken in the evening (when their target gene was most active). Longer-acting
statins show no changes in efficacy based on the time of administration. The flexibility
offered by these latter statins may serve to increase patient compliance, and ultimately
improve their health outcomes. This is one example among many, demonstrating the
ability of chronotherapeutic practices to positively impact drug treatment.
Nevertheless, the influence of time-of-administration on the majority of
pharmaceuticals on the market today has not been extensively studied, and circadian
effects are not a routine aspect of drug efficacy and safety trials. Our data indicate that
circadian genes are highly associated with diseases, and many of the most commonlyused medications in the world target circadian genes. Furthermore, our data indicate: a)
the majority of the top-selling drugs on the market have circadian targets, and b) a
substantial fraction have half-lives less than six hours (Dataset S3). These data allow for
prospective chronotherapeutic studies, as they indicate which drugs are sensitive to
time-of-day administration, and when and where they may do so. This is illustrated by
the example we provide in the results, where we hypothesize that circadian oscillations
in expression of the aspirin target gene, Ptgs1, are responsible for rhythms in aspirin's
cardio-protective effects. More broadly, these data will be a great resource for the field,
and we invite the reader to explore this data through our web interface
(http://bioinf.itmat.upenn.edu/circa).
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Methods
Animal preparation and organ collection: Mice were prepared as previously
described(Hughes et al. 2009). Briefly, 6-week old male C57/BL6 mice were acquired
from Jackson Labs, entrained to a 12h:12h light:dark schedule for one week, then
released into constant darkness. Starting at CT18 post-release, three mice were
sacrificed in the darkness every 2h, for 48 hours. Specimens from the following organs
were quickly excised and snap-frozen in liquid nitrogen: aorta, adrenal gland, brainstem,
brown fat (anterior dorsum adipose), cerebellum, heart, hypothalamus, kidney, liver, lung,
skeletal muscle (gastrocnemius) and white fat (epididymal adipose). Food and water
were supplied ad libidum at all stages prior to sacrifice. All procedures were approved by
the Institutional Animal Care and Use Committee.
Microarray data: Organ samples were homogenized in Invitrogen Trizol reagent
using a Qiagen Tissuelyser. RNA was extracted using Qiagen RNeasy columns as per
manufacturer’s protocol, then pooled from three mice for each organ and time point. The
reason for pooling was to average out both biological variance between individual
animals and technical variance between individual dissections. RNA abundances were
quantified using Affymetrix MoGene 1.0 ST arrays and normalized using Affymetrix
Expression Console software (RMA). Probesets on the Affymetrix MoGene 1.0 ST array
were cross-referenced to best-matching gene symbols using Ensembl BioMart software,
then filtered for known protein-coding status. The resulting 19,788 genes formed the
protein-coding background set.
RNA-sequencing data: RNA samples from CT22, CT28, CT34, CT40, CT46,
CT52, CT58, and CT64 were pooled for each organ, as described above (96 total pools).
These RNA pools were converted into Illumina sequencing libraries using Illumina
43	
  
	
  

TruSeq Stranded mRNA HT Sample Preparation Kits as per manufacturer’s protocol.
Briefly, 1 ug of total RNA was polyA-selected, fragmented by metal-ion hydrolysis, and
converted into double-stranded cDNA using Invitrogen Superscript II. The cDNA
fragments were subjected to end-repair, adenylation, ligation of Illumina sequencing
adapters, and PCR amplification. Libraries were pooled into groups of six and
sequenced in one Illumina HiSeq 2000 lane using the 100bp paired-end chemistry (16
lanes total). Details on alignment and quantification are included in the Supplementary
Methods.
Oscillation detection: The JTK_CYCLE(Hughes et al. 2010) package for R was
used, with parameters set to fit time-series data to exactly 24h periodic waveforms.
Significance was bounded by q<0.05 for array data sampled at 2h and by p<0.05 for
sequencing data sampled at 6h.

Supplementary Methods
Quantifying and aligning RNA-sequencing data: Fastq files containing raw RNAseq reads were aligned to the mouse genome (mm9/NCBI37) using STAR(Dobin et al.
2013) (default parameters). RNA-seq quantification was performed using HTSeq(Anon
n.d.), run in stranded mode (default parameters). Protein-coding genes were quantified
using the Ensembl annotation(Flicek et al. 2012). Non-coding RNAs were quantified
using data from the NONCODE v3 database(Bu et al. 2012). Quantification values were
normalized using DESeq2(Anders & Huber 2010).
Identifying non-coding RNAs conserved between humans and mice: We began
by downloading BED files listing ncRNA coordinates for humans and mice from the
NONCODE v3 database. These bed files contained 33,801 human and 36,991 mouse
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transcripts. To prevent overlapping ncRNAs from confounding the analysis (many of
these appeared to be alternative spliceforms of the same ncRNAs), we merged all
overlapping ncRNAs on the same strand using the BEDTools suite(Quinlan & Hall 2010).
This merge step resulted to 20,042 human and 27,286 mouse transcripts. Using the
coordinates for these merged transcripts and the UCSC Genome Browser(Meyer et al.
2013), we downloaded the nucleotide sequences corresponding to each of these
ncRNAs in FASTA format. Next, we constructed separate human and mouse BLAST
libraries from these ncRNA sequences by running the makeblastdb command with
default parameters. Following this, we used BLAST(Altschul et al. 1990) to align the
mouse ncRNA sequences against the human ncRNA BLAST library, and vice-versa.
Since ncRNAs have previously been shown to have relaxed constraints on sequence
conservation(Washietl et al. 2014), we ran blastn using the more permissive dcmegablast algorithm and a minimum e-value cutoff of 1E-10. We then mined these
BLAST results for pairs of human and mouse ncRNAs that were each other’s top BLAST
hit (termed “reciprocal best hits”). Filtering for these reciprocal best hits left us with 1601
human and mouse transcript pairs, we termed conserved ncRNAs. We are confident in
our ability to identify conserved ncRNAs using these relaxed BLAST parameters as we
successfully found well-known, conserved ncRNAs like Xist, Tsix, Hotair, H19, and Gas5.
To assign names and annotation data to these conserved ncRNAs, we used
BLAST to align their sequences to human and mouse RefSeq(Pruitt et al. 2009)
transcripts. We found 585 of these conserved ncRNAs mapped to protein-coding genes
(ie. RefSeq IDs beginning with NM or XM) in the sense orientation in both humans and
mice. Upon visual inspection of these ncRNAs, we found that many of these mapped
along the entire length of the protein-coding transcripts. While some ncRNAs in this list
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might represent non-coding isoforms of these protein-coding transcripts, we chose to
take a conservative approach and removed these from further analysis. Following the
removal of these transcripts, we were left with a final list of 1016 conserved ncRNAs. We
assigned biotypes (defined by GENCODE(Harrow et al. 2012) and Ensembl) to these
transcripts using both Ensembl and manual annotation. Quantification and analysis of
these transcripts was performed like all other RNA-seq transcript data, as described in
the Methods section of the paper.
Identifying novel ncRNAs: Given that RNA-seq data is not limited to a specific
gene annotation, we sought to characterize novel transcripts. We began by collecting all
reads that mapped across splice junctions (ie. reads with large gaps in their alignments).
Reads falling into this class are identified by STAR during alignment and stored in files
having with the SJ.out.tab extension. While this will cause us to miss single-exon
transcripts, we have greater confidence that the data comes from a real, expressed
transcripts if we see evidence of RNA splicing. To reduce the impact of spurious reads
and noise, we required that splice junctions be mapped by a minimum of 16 reads
across our entire dataset (this corresponds to 2 reads per time point in a single orgran).
We chose a fairly low threshold so as not to remove junctions present in only a single
organ, and those circadian transcripts expressed in a bursting patterns (like Dbp). Next,
we used the BEDTools to filter out any junction mapping within 1KB of any Ensembl or
Refseq transcript, or overlapping with any NONCODE transcript. All of these steps left
us with 10,452 junctions from putative transcripts. We merged all junctions within 500 bp
of each other to form 5,154 putative, ncRNA transcript regions. These putative
transcripts were quantified and analyzed like all other RNA-seq transcripts, as described
in the Methods section of the paper.
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Disease-genes, drug targets, and other data sources: Disease-gene annotations
were aggregated from the following sources: Online Mendelian Inheritance in
Man(Hamosh et al. 2005), Universal Protein Resource(Anon 2013b), Comparative
Toxicogenomics Database(Davis et al. 2013), Pharmacogenomics
KnowledgeBase(Whirl-Carrillo et al. 2012), Literature-Derived Human Gene-Disease
Network(Bundschus et al. 2008). Drug target genes were pulled from the DrugBank
database(Law et al. 2014). List of WHO essential medicines downloaded from WHO
website(Anon n.d.). National Institutes of Health (NIH) funding estimates for fiscal year
2013 from the NIH Research Condition, and Disease Categories system (Anon 2013a).
MicroRNA target predictions for PTGS1 from TargetScan(Lewis et al. 2005)
Tissue culture and cell maintenance: NIH3T3 cells were purchased from ATCC.
These cells were maintained in growth media containing 10% FBS (Atlanta Biologicals),
1X Penicillin/Streptomycin/Glutamine (Gibco), and 1X Non-essential amino acids (NEAA;
Gibco) in Dulbecco’s Modified Eagle’s medium (DMEM; Gibco). Cells were grown in a
humidified incubator at 37ºC and 5% CO2.
Transfections: All transfections were performed in the forward format. Briefly,
cells were seeded in 6-well dishes at a density of 2.5x105 cells/well, in media containing
no antibiotics (DMEM, 10% FBS, 1X Glutamine (Gibco), 1X NEAA). Cells were
incubated overnight at 37ºC and 5% CO2. On the following day, cells were transfected
using Opti-MEM (Gibco) and the RNAiMAX (Invitrogen) reagent, according to
manufacturer’s protocol. Cells were transfected with mirVana Negative Control #1, mmumiR-22-3p mimic, or mmu-miR-22-5p mimic (Life Technologies), at a final concentration
of 50 nM. Transfected cells were incubated for 72 hrs at 37ºC and 5% CO2. RNA and
protein were harvested from the same well by collecting cells in ice-cold PBS, and
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dividing these cells suspensions into two aliquots. For each well, one aliquot was
processed for protein, and the other was processed for RNA.
Western blot: Whole-cell protein extracts were isolated from cells using ice-cold
RIPA buffer (Sigma), supplemented with Complete protease inhibitor cocktail (Roche).
Protein concentrations were quantified using the DC protein assay (BioRad). 4 µg of
protein was resolved on 7.5% polyacrylamide, Tris-HCL/Glycine/SDS gels (BioRad) and
transferred to PVDF membranes. Membranes were blocked for 1 hr at room temperature
in blocking solution (5% milk, 0.05% Tween20, 1X Tris-buffer saline), followed by
overnight incubation at 4ºC with primary antibody in blocking solution. Primary
antibodies used were: anti-PTGS1 (160110; Cayman Chemical), and anti-GAPDH (sc25778; Santa Cruz). Membranes were then rinsed twice each with TBS-0.05% tween
and blocking solution. Following rinses, membranes were probed with secondary
antibody at room temperature for 70 min. Those membranes treated with anti-PTGS1
were incubated with anti-mouse IgG HPR-linked secondary antibodies (NA931V; GE
Healthcare), while membranes treated with anti-GAPDH were incubated with anti-rabbit
IgG HPR-linked secondary antibodies (NA934-1ML; GE Healthcare). Membranes were
then rinsed 5 times for 10 min in TBS-0.05% tween, and then imaged using standard
autoradiograph techniques after the application of Western Lightning Plus ECL
(PerkinElmer) western blotting detection reagent.
RNA extraction and Quantitative PCR: RNA was extracted from cells using
TRIzol reagent (Life Technologies) with Direct-zol RNA MiniPrep kit (Zymo research),
according to manufacturer’s protocol, cDNA was generated from 500 ng of RNA using
the qScript cDNA Synthesis Kit (Quanta Biosciences) and qPCR was performed on the
ViiA 7 Real Time PCR System (Life Technologies) using the PerfeCTa FastMix II, Low
ROX reagent (Quanta Biosciences), according to the manufacturer’s protocols. Relative
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expression quantification of the qPCR data was performed using the ΔΔCT method with
the ViiA 7 analysis software v1.2 (Life Technologies). Ptgs1 (Mm00477214_m1; Life
Technologies) was quantified using Gapdh (4352661; Life Technologies) as the
endogenous reference.
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CHAPTER 3:
DISCOVERING GENE-PHASE SET ENRICHMENT

Life evolved on a rotating planet. As a consequence, biological adaptations to the
phenomenon of oscillation are some of the most fundamental and well-preserved
features of living organisms. It is increasingly clear that the disruption of an animal’s
normal circadian rhythms leads to major health problems, affecting glucose homeostasis,
lipid metabolism, cardiovascular disease, and chemotherapeutic sensitivity(Martino et al.
2008; Scheer et al. 2009; Buxton et al. 2012). Mutations in genes controlling the
circadian clock result in increased sensitivity to mutagens(Fu et al. 2002; Hoffman et al.
2010), while alterations in cell cycle checkpoints precede cancer(Kastan & Bartek 2004).
Shift work is epidemiologically linked to increased risk of obesity(De Bacquer et al. 2009),
diabetes(Maury et al. 2010), cardiovascular disease(Faraut et al. 2012), and cancers of
the breast(Davis et al. 2001; Grundy et al. 2013), prostate(Flynn-Evans et al. 2013),
endometrium(Viswanathan et al. 2007), and other organs(Sahar & Sassone-Corsi 2009;
Parent et al. 2012).
However, despite our appreciation for the significance of biological rhythms,
translation into medically actionable knowledge has been elusive. Which diseases
modulate which rhythms? How do rhythms affect the appropriate timing of medications
or onset of symptoms? Most simply, how do rhythmic processes influence cellular
physiology? This deficiency in our understanding is not due to a simple lack of data.
Hundreds of time series gene expression studies from all manners of tissues and
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experimental conditions have been published(Zhang et al. 2014; Bossé et al. 2012;
Ptitsyn & Gimble 2011). The complexity of the temporal relationships between rhythmic
genes, compounded by the large number of genes involved, make a high-level
understanding of the biology difficult. Better tools are needed to incorporate known
biology into the intepretation of rhythmic data.
Numerous databases of gene annotations exist, such as the Gene
Ontology(Anon 2008), KEGG(Kanehisa et al. 2014), and Reactome(Croft et al. 2014).
Genes that share functional annotations are often considered usefully as a set. For
example, genes involved in the Krebs cycle might form one set, while genes associated
with Parkinson’s disease might form another. The Broad Institute maintains a fairly
comprehensive database of important known gene sets, called the Molecular Signature
Database (MSigDB)(Subramanian et al. 2005). Researchers often want to discover how
a set of genes that has been identified in the lab, for example a list of circadian genes
identified in an experiment, overlaps with other known functional sets such as the Krebs
cycle or Parkinson’s disease genes.
The traditional approach to this type of analysis is to test for over-representation. Genes
are essentially partitioned into a contigency table, whose distribution is examined using
the Chi-square test, Fisher’s exact test, or some other variation. NIH DAVID(Huang et al.
2009b) and GoMiner(Zeeberg et al. 2003) are examples of popular web tools that use
this approach. However, over-representation analysis has important disadvantages
which have been well-recognized in the literature(Huang et al. 2009a; Irizarry et al.
2009), including the need for a strict significance cutoff that is often selected arbitrarily.
Temporal data is also typically binned into discrete windows or clusters, with each bin
analyzed independently. Statistical power is reduced due to multiple testing as well as
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the arbitrary suboptimal binning strategy. Thus, more modern approaches based on the
concept of aggregate scoring have been developed. These methods attempt to assign
gene sets a score that is derived from allowing individual genes to contribute by differing
degrees. Tools based on a z-score(Tian et al. 2005) or t-test(Tian et al. 2005) have been
published, but the most popular aggregate score-based tool is GSEA(Subramanian et al.
2005), which is based on a weighted Kolmogorov-Smirnov test. Such tools have
generally been quite successful for researchers.
However, one glaring situation in which these aggregate-score based tools fall short is in
the case where data come from a cyclic domain, for example circadian data. A problem
arises because existing tools assume a linear domain, in which small values on the
domain are far away from large values. However, in a cyclic domain, small values are
very close to large values. For example, CT23 is very close to CT0. Thus, GSEA and
others like it are simply inappropriate if a researcher wishes to discover enrichment
amongst gene-phase sets.
In this paper, we describe an appropriate way to identify gene-phase set
enrichment in data from a cyclic domain. We perform simulations to verify the reliability
of our approach, then apply the approach to several biological datasets to answer some
standing questions in the field. These topics are organized and presented as four case
studies. Our findings reveal a number of biological pathways that are active in mouse
brown adipose and skeletal muscle during the time window spanning the CT0/24
breakpoint, which are difficult to detect with current methods. Moreover, we discover
temporally organized gene sets with bi-modal expression patterns that might be missed
using the typical over-representation analysis. We also examine gene-phase sets from
mice in two different perturbed states: restricted feed time and restricted sleep time. We
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discover that one perturbation has a more dominating influence on shifting physiology
than analysis of individual gene phases might suggest, while, in contrast, the other
reduces the number of cycling genes but has suprisingly little influence on the phases of
gene sets that continue to cycle. Under conditions of restricted feed time, degradation
pathways appear to decouple from synthesis pathways, as the balance in timing
between them is disrupted. We show that unique targets of the core circadian
transcription factor, CLOCK, behave very differently from unique targets of either
CLOCK’s partner, BMAL1, or any other core circadian transcription factor. Finally, we
examine and compare the cell cycles of two cancer lines, HeLa and U2OS, to show that
gene-phase set enrichment can be applied in many other contexts involving biological
periodicity.

Gene-phase set enrichment algorithm
Our approach to discovering gene-phase set enrichment has three steps. The
first step is to identify which biologically-related gene sets consist of genes with very
non-uniformly distributed phases. The intent is to identify sets whose genes cluster by
phase. Because the data come from a cyclic domain, we require a statistical that is
invariant under cyclic transformation and uniformly powerful across a cyclic domain. The
inability of GSEA and other existing methods of its class to meet this requirement has
prevented that existing repertoire of tools from being useful for examining oscillation
phases. We found the Kuiper test(Kuiper 1962) to be an excellent choice for this step.
This non-parametric test compares a sample probability distribution to a reference
distribution, quantifying the general amount of dissimilarity between the two distributions.
Its null hypothesis is that the two distributions are the same. The test statistic is the sum
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of two quantities: the largest difference in cumulative probability of the first distribution
from the second at any single position of the domain, and the largest difference in
cumulative probability of the second distribution from the first at any single position of the
domain.
To verify that the Kuiper test satisfies our cyclicity requirements, we applied the
test repeatedly to synthetic data drawn from a variety of simulated von Mises
distributions against a uniform reference distribution (Figure 3.1). The von Mises
distribution, also known as the circular normal distribution, takes two parameters: mean
(µ) and reciprocal variance (κ). In our simulations, we systematically changed both µ and
κ, to produce a gamut of von Mises distributions from which to draw samples. Changes
to µ produced cyclic translation, while increases to κ reflected departure from uniformity.
We also systematically changed the sample sizes drawn from these distributions, to
analyze the Kuiper test’s statistical power. For comparison, the Kolmogorov-Smirnov test,
on which the current most popular gene set enrichment analysis tool is essentially based,
was also examined. Our results show that the Kolmogorov-Smirnov test has wildly
fluctuating statistical power across a cyclic domain, achieving its maximum power at only
two positions within the domain while being considerably inferior elsewhere. In stark
contrast, the Kuiper test is not only invariant under cyclic transformation and uniformly
powerful across a cyclic domain, but its power is also consistently comparable to the
Kolmogorov-Smirnov test’s maximum power throughout the entire domain. Thus, current
gene set enrichment approaches based on the Kolmogorov-Smirnov test are absolutely
unsuitable for cyclic phase analysis.
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Figure 3.1: Simulated Kolmogorov-Smirnov (KS) test and Kuiper test results.
Von-Mises distributions at different parameters of µ and κ were sampled and tested against the
uniform distribution. X-axes show different values of µ. Columns contain different values of κ.
Colored lines indicate sampling at different sample sizes, ranging from dark blue (N=10) to
orange (N=50). A) Y-axes show test results in terms of negative logarithmic p-values. B) Y-axes
show test results in terms of specificity and sensitivity.
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Once a non-uniformly distributed (clustered) gene-phase set has been identified,
the next step is to identify the relative contribution of each gene in that set towards the
set’s non-uniformity. Which genes contribute most to phase clustering? For this step, we
have developed a “leave one out” approach. A gene is removed from the set and the
Kuiper statistic is calculated for the remainder of the set. The gene is then replaced,
while another gene is removed, and the Kuiper statistic is re-calculated for the remainder
of the set. This process is repeated until each gene has been removed once from the set.
Genes that contribute more strongly towards phase clustering will lead to a lower Kuiper
statistic when removed, and vice versa. In this way, the subset of genes comprising the
main cluster(s) in any set are straightforward to identify.
The last step is to distinguish whether or not a set has uni-modal phase
clustering, since multi-modal clustering can appear in a number of biological contexts.
For example, bi-modal phase clustering, in which two clusters that are 12 hours apart
(dusk and dawn), has been observed with great interest in circadian data(Zhang et al.
2014; Hughes et al. 2009). A simple vector averaging approach works well here. When a
set’s individual gene phases are represented vectorially in radial space, the twodimensional average of those vectors will have a large magnitude if phases are
distributed uni-modally. Otherwise, this magnitude will be small.
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Case study 1: mice in the natural state
Our lab has recently published an atlas of circadian gene expression in the
mouse, quantifying the transcriptomes of 12 different mouse organs from wild-type mice
in their natural state(Zhang et al. 2014). We have revisited that dataset in order to
analyze gene-phase set enrichment within those organs. Gene set annotations were
obtained from MSigDB, with a focus on the C2:CP collection of canonical pathways.
We found that circadian genes in mouse brown adipose and skeletal muscle both
predominantly comprise pathways whose gene phases cluster near dawn (Figure 3.2
and Figure 3.3). These sets are difficult to detect using current gene set enrichment
analysis tools because their phases concentrate in a region that is discontinuous on the
linear time domain: the breakpoint of CT0/24. However, these sets were straightforward
to detect using our algorithm. “Extracellular matrix organization” in brown adipose and
“leukocyte transendothelial migration” in skeletal muscle were two prime examples that
we uncovered (Figure 3.2B and Figure 3.3B), which we could not found by NIH DAVID.
We were equally able to detect pathways clustered at other times of the day away from
the breakpoint, such as “glycerophospholipid metabolism,” which clustered in the midday hours in brown adipose. “Metabolism of lipids and lipoproteins” and “metabolism of
proteins” were two pathways we found to have bi-modal phase clustering (dusk and
dawn) in brown adipose.
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Figure 3.2: Phase-clustered pathways in brown adipose.
A) Summary diagram of significant (Kuiper p-value < 0.0001) pathways. Circular axis (angle)
represents the vector-average phase CT hour of all circadian genes in a pathway. Larger fontsize of pathway name indicates larger magnitude of this vector-average (more uni-modal).
Pathways along the outside of the circle had gene phases distributed primarily into one cluster,
while pathways along the inside had gene phases distributed into multiple clusters. B) Examples
of two pathways along the outside (uni-modal) and two pathways along the inside (bi/multi-modal)
of panel A. X-axes show individual gene phase CT hour. Y-axes show proportion of genes.
Orange bars depict probability distribution of the individual genes in a pathway. Orange line
depicts cumulative distribution of orange bars. Blue line depicts cumulative distribution of the
uniform distribution, against which each pathway was tested for non-uniformity by the Kuiper test.
Individual gene names are shown where permitted by figure space, with larger font-size of a gene
name indicating greater contribution by that gene towards overall phase clustering of a pathway.

58	
  
	
  

Figure 3.3: Phase-clustered pathways in skeletal muscle.
See Figure 3.2 for panel legends.

We also examined another similar dataset previously published by Hughes et
al.(Hughes et al. 2009) that was derived from mouse liver. Here, we took an additional
step to estimate gene phases from this dataset by two different methods:
JTK_CYCLE(Hughes et al. 2010) and Lomb-Scargle(Glynn et al. 2006). These are two
of the most popular methods for circadian rhythm detection, but they are known to
produce different phase estimates from each other under different conditions(Deckard et
al. 2013). We found our method for analyzing gene-phase set enrichment was robust to
those phase-estimate differences, producing nearly identical results at the gene set level
(Figure 3.4). Pathways involving the metabolism of drugs, purines and pyrimidines were
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revealed to cluster in the early night hours in both cases, despite discrepancies between
phases assigned to the individual genes involved. Much like how an aggregate statistic
such as a median confers robustness against individual outliers, phase enrichment at
the set level showed robustness against individual genes.

Figure 3.4: Comparison of phase-clustered pathways in liver derived from two different algorithms
for estimating individual gene phases.
A) Individual gene phase estimates were obtained using JTK_CYCLE prior to gene-phase set
enrichment analysis. B) As per panel A, except Lomb-Scargle was used in place of JTK_CYCLE.

Case study 2: mice in a perturbed state
After studying data from mice in their natural state, we became interested in how
perturbations might shift the normal physiology. It has been previously shown that the
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time at which an animal is fed can synchronize the circadian clocks of peripheral tissues
such as the liver. Vollmers et al.(Vollmers et al. 2009) showed that this influence of
feeding time is so strong that when mice who normally eat at night are restricted to eat
only during the day, the majority of preserved rhythmic genes in their livers shift phase
by at least 6 hours. However, a significant minority of genes are relatively unaffected and
it has been a standing question as to whether these shift-resistant genes are functionally
related in some way. More generally, it remains unclear whether shifted feeding time
alters the relative temporal organization of metabolism. This question is important
because altered feeding time has been shown to lead to obesity in several mouse
strains.
Here, we were not interested in gene phases themselves, but rather in genephase differences between the control and experimental conditions (ad libitum and
restricted feeding, respectively). Vollmers et al. indicated that 84% of these phase
differences were greater than 6 hours absolute value. However, our analysis for gene
set enrichment in the data from Vollmers et al. showed that 100% of MSigDB gene sets
with non-uniformly distributed phase differences had an average shift greater than 6
hours absolute value (Figure 3.5A). Not a single known pathway, motif, gene ontology,
or other functional gene set remained unshifted. Feed time utterly and completely
dominates the synchronization of rhythmic physiology in this organ, to a far greater
extent than analysis of individual genes might suggest.
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Figure 3.5: Comparison of phase shifts between the individual gene level and the gene-set level
after two different perturbations.
A) Restricted feed time perturbation. B) Restricted sleep time perturbation.

The core circadian oscillator pathway itself shifted by almost exactly 12 hours, as
did pathways involving immune signaling, endocytosis, and various other aspects of cellcell communication. Unexpectedly, we found that synthesis pathways such as
gluconeogenesis and synthesis of bile salts, ATP, steroids, and fatty acids tended to
shift by about 9 to 10 hours following restricted feed time, while degradation pathways
such as apoptosis and degradation of E3 ubiquitin ligase, CDH1, CDC20, and
glycosaminoglycans tended to shift by about 13 to 14 hours (Table 3.1). This result was
surprising, as one might intuitively expect degradation and synthesis to be coupled
62	
  
	
  

events that maintain a tight temporal relationship with each other. Instead, it appears
that restricted feeding may upset the relative temporal coordination between degradation
and synthesis in the liver. This disruption, in turn, would likely lead to altered metabolite
levels over time.

Set ID

Phase-shift

KEGG_AMINOACYL_TRNA_BIOSYNTHESIS

9.353812

REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC...

9.628014

REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C

9.648053

REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LI...

9.648053

REACTOME_HS_GAG_DEGRADATION

9.80608

REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_...

9.953659

REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MI...

10.06455

REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G

10.06455

REACTOME_SYNTHESIS_OF_PE

10.36397

REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21

10.52056

REACTOME_SYNTHESIS_OF_DNA

11.16291

KEGG_N_GLYCAN_BIOSYNTHESIS

11.22514

REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOM...

11.78409

KEGG_LYSINE_DEGRADATION

11.91448

REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROT...

11.96836

REACTOME_SYNTHESIS_OF_PA

12.05773

REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE

12.1565

REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS

12.16069

KEGG_FOLATE_BIOSYNTHESIS

12.48591

KEGG_STEROID_HORMONE_BIOSYNTHESIS

12.53575

REACTOME_HS_GAG_BIOSYNTHESIS

12.67666

REACTOME_TRIGLYCERIDE_BIOSYNTHESIS

12.68183

KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION

12.72324

REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLE...

12.84358

REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACY...

12.84801

REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS

12.97549

REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS

13.05611

REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS

13.07659

REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PR...

13.41876

KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS

13.75729
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REACTOME_CHOLESTEROL_BIOSYNTHESIS

14.02924

KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS

14.24818

KEGG_RNA_DEGRADATION

14.35378

KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS

14.41215

KEGG_STEROID_BIOSYNTHESIS

14.49358

REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYN...

14.59261

REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS

14.6068

REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS...

14.6068

Table 3.1: Phase shift of degradation or synthesis pathways after restricting feeding time.
Bolded pathways involve degradation. Italicized pathways involve synthesis.

What if, instead of feed time, the animal’s sleep time is shifted instead? MöllerLevet et al.(Möller-Levet et al. 2013) have previously published an experiment in which
mice who normally sleep during the day were not allowed to sleep during the first half of
the daytime period. The study was intended to model shiftwork, which is thought to
contribute to the modern rise in obesity and metabolic syndrome among humans. The
authors concluded that sleep restriction led to a “global disruption of diurnal liver
transcriptome rhythms, enriched for pathways involved in glucose and lipid metabolism.”
Using a similar approach as for restricted feeding, we examined the differences
in liver gene phases between conditions of normal and restricted sleep. About 75% of
rhythmic genes in the normal condition actually became arrhythmic in the restricted
sleep condition and thus were not suited for questions about phase shifts. We analyzed
the remaining 25% of genes. About half of these genes did not shift phase, while the
other half did. However, at the gene set level, 100% of MSigDB gene sets with nonuniformly distributed phase differences had an average shift of less than 6 hours
absolute value (Figure 3.5B). This result was the exact reverse of what we found for
restricted feeding. Thus, whereas feed time had a dominating influence on shifting the
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phases of rhythmic biology in the liver, sleep time had relatively little influence in this
regard. However, restriction of sleep time had a much stronger ability to abolish gene
rhythms altogether.

Case study 3: binding of the core circadian transcription factors to DNA
The core circadian transcription factors are canonically thought to work in groups.
For example, CLOCK and BMAL1 are typically thought to regulate the same genes
together as a dimer. However, Koike et al.(Koike et al. 2012) have recently published
that individual core factors also bind rhythmically to their own unique subsets of genes
independent of other core factors. In fact, the authors noted that CRY1, CRY2, and
PER2 seemed to bind especially large numbers of genes uniquely. This result intrigued
us, begging the question of whether there was anything special about genes that are
uniquely bound by an individual core factor, especially with regards to gene phase and
timing.
We cross-referenced Koike et al.’s lists of genes that were rhythmically bound by
each core factor in the liver with liver gene phases published by Hughes et al. We found
that rhythmic genes bound by each of the individual factors, not necessarily uniquely,
had phases spanning all times of the day. This phenomenon had been noted by Koike et
al. to suggest that post-transcriptional mechanisms must have a major role in regulating
the phases of mRNA rhythms. Using our phase set enrichment approach against these
background phase distributions, we found that rhythmic genes uniquely bound by most
of the individual factors also had phases spanning all times of the day. However, genes
uniquely bound by CLOCK were the sole exception.
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Our algorithm detected the set of rhythmic genes uniquely bound by CLOCK to
have a significantly different phase distribution from the background set of all rhythmic
genes bound by CLOCK (p<0.001, Figure 3.6). There were 15 rhythmic genes uniquely
bound by CLOCK: Alg6, Gnb2l1, Atp5c1, Pkig, Poc1b, Angel2, Zfp354b, Arl16, Med21,
Mphosph6, Mrps6, Ifitm2, Rps6kb1, Sept10, and 3110001i22rik. Nearly all of them had
peak transcript levels during the early night. In contrast, unique targets of CLOCK’s
canonical partner, BMAL1, had peak transcript levels at all times of the day, with phases
that were not significantly differently distributed than for other BMAL1 targets. Unique
targets of other core factors also did not cluster significantly. This result is very thoughtprovoking as it suggests that CLOCK may have an unrecognized additional regulatory
function that does not involve BMAL1 or the canonical circadian oscillator. Furthermore,
this additional function may even bypass post-transcriptional mechanisms of target-gene
phase control that are present for other core factors. CLOCK may be dimerizing with a
different partner than BMAL1, or it may be acting alone. Further studies will be needed
to make this determination.
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Figure 3.6: Phases of circadian genes targeted by core clock transcription factors.
X-axes show phase CT hour of target genes. Y-axes show proportion of genes. Orange bars
indicate circadian genes uniquely targeted by a factor. Blue bars indicate all circadian genes
targeted by a factor. Orange and blue lines show the cumulative distributions derived from the
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probability distributions of the orange and blue bars, respectively. Gene names are shown as
permitted by figure space, with larger font-size indicating greater contribution by a gene to the
overall phase clustering in a gene set.

Case study 4: the cell cycle of two cancer cell lines
While the focus of our lab is circadian rhythms, it has not escaped us that phase
set enrichment analysis will be a useful technique in a number of other biological
contexts as well. The cell cycle is a prime example. It is a centrally relevant phenomenon
in cancer. In 2002, Whitfield et al.(Whitfield et al. 2002) published a seminal dataset of
periodically expressed genes in the HeLa cervical cancer cell line. Recently, Grant et
al.(Grant et al. 2013) have published a similar dataset for the U2OS osteosarcoma
cancer cell line. Both studies used the cell cycle to define the periodic time domain and
identified hundreds of cell-cycle regulated genes. Both studies also used NIH DAVID to
discover gene set enrichment. We sought to re-examine these datasets using phase set
enrichment, to compare the two cancer cell lines with each other. Figures 3.7 and 3.8
highlight the gene sets detected for HeLa and U2OS, respectively.
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Figure 3.7: Summary diagram of pathways comprising cell-cycle periodic genes in HeLa cells.
Cell-cycle checkpoint labels for S and M phases derived from the phase vector-averages of the
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“KEGG_DNA_REPLICATION” and “REACTOME_MITOTIC_PROMETAPHASE” pathways,
respectively. Labels for G1 and G2 were superimposed midway between S and M.

Figure 3.8: Summary diagram of pathways comprising cell-cycle periodic genes in U2OS cells.
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We found that the fraction of periodic genes shared in common between the two
cell lines was very small, but that the fraction of functional gene sets shared was much
larger (Figure 3.9A). Nearly all of these shared sets corresponded to pathways involved
in, or related to, mitosis or DNA synthesis. While not an entirely surprising result given
the nature of the data, it again highlighted that set-level analysis provided a level of
robustness towards understanding of the data that gene-level analysis might miss. In
both cell lines, we used the phase vector average of the “Reactome mitotic
prometaphase” set to define the approximate position of the M phase along the cyclic
time domain, and that of the “KEGG DNA replication” set to define the approximate
position of the S phase. We found that the G1 phase comprised a much larger portion of
the HeLa cell cycle than of the U2OS cell cycle, while the opposite was true for the G2
phase.
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Figure 3.9: Overlap of cell-cycle periodic genes and gene sets between HeLa and U2OS cells.
A) Overlap of individual genes. B) Overlap of gene sets.

Of note was that sets unique to one cell line and not the other may reflect
pathways that are more likely to be dysregulated in one as compared to the other.
Pathways that were uniquely significant (p<0.001) in HeLa cells included “KEGG MAPK
signaling pathway,” “KEGG FAS pathway,” “KEGG base excision repair,” and “PID
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caspase pathway,” while pathways that were uniquely significant in U2OS cells included
“PID E2F pathway,” “Reactome chromosome maintenance,” “Reactome telomere
maintenance,” “KEGG spliceosome,” “Reactome kinesins,” and “KEGG p53 signaling.”
All of these pathways should, in theory, be coupled to the cell cycle. Thus, a cell line
which did not show significance in one of these pathways may have lost its coupling,
compatible with the cancer phenotype.

Discussion
We have presented an approach for detecting phase set enrichment that
addresses an important gap in the field. Moving forward, we expect that this approach,
or some variation of it, will become increasingly important and oft-used as researchers
produce more and more big datasets in the circadian, cell-cycle, or other similar fields.
Use of methods that are invariant under cyclic transformation and uniformly powerful
across the cyclic domain will be critical for properly extracting biological insights from
these data.
Besides using this approach to analyze gene phases themselves, we also
demonstrated that interesting questions can be addressed when it is the phase shifts
that are analyzed (case study 2). The finding that degradation pathways tend to shift by
a different amount than synthesis pathways do, despite the entire organism having been
subject to a single gross shift in feed time, suggests that degradation and synthesis may
not be coupled in a straightforward way. This has direct medical implications, since
human disorders that involve feed time shifts, such as night eating syndrome or
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nocturnal sleep-related eating disorder, have been directly linked to a number of bad
health outcomes(Birketvedt et al. 1999; Schenck & Mahowald 1994).
The finding that CLOCK’s unique gene targets cluster in phase, while other core
circadian transcription factors’ unique targets do not, is especially intriguing because the
implications of this finding break canon. How can CLOCK be doing something so
differently from what BMAL1 is doing? Does CLOCK have another partner that it has
thus far been meeting in secret? What post-transcriptional mechanisms regulate
circadian output-gene phase and do they apply to CLOCK’s unique targets? These are
immediate questions that we have given the unexpected finding.
We have made a downloadable Java implementation of our gene-phase set
enrichment algorithm available at the Hogenesch lab website. As problems of periodicity
continue to arise in many areas of biology, it is our hope that the research community
finds such a tool as useful as we have.

Methods
Algorithm: Java 1.5 was used for our in-house implementation of the gene-phase
set enrichment analysis algorithm as well as for all validation simulations presented. Our
java implementation can be downloaded at the Hogenesch lab website.
Case study 1: For analysis in brown adipose and skeletal muscle, circadian gene
lists were downloaded directly from the published supplementary materials of Zhang et
al.(Zhang et al. 2014). Kuiper tests were performed with significance threshold of p <
0.001. For the comparison of JTK_CYCLE against Lomb-Scargle, expression data were
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downloaded from the supplementary materials of Hughes et al.(Hughes et al. 2009) and
reprocessed using either JTK_CYCLE (v2.1) or Lomb-Scargle. JTK_CYCLE was run
with parameters to fit the data to only and exactly 24-hour periods. A significance
threshold of q <0.05 was used to bound results from both JTK_CYCLE and LombScargle analyses. Gene sets were downloaded from MSigDB(Subramanian et al. 2005).
Sets containing fewer than 5 rhythmic genes were ignored during gene-phase set
enrichment analysis.
Case study 2: Lists of oscillatory genes and their phases were downloaded
directly from the supplementary materials of Vollmers et al.(Vollmers et al. 2012) and
Möller-Levet et al.(Möller-Levet et al. 2013). Thus, we accepted all rhythmicity calls
made in their respective original publications. Gene sets and enrichment analysis
settings were the same as for case study 1.
Case study 3: Lists of target genes for each core clock transcription factor were
obtained from the “Master peak list” within the supplementary materials of Koike et
al.(Koike et al. 2012). These lists were cross-referenced with circadian genes found in
mouse liver by the analysis of Hughes et al. using JTK_CYCLE, described in case study
1, in order to assign phases to the target genes. Target genes from Koike et al. that
could not be assigned a phase due to non-appearance in the Hughes et al. dataset were
ignored during gene-phase set enrichment analysis.
Case study 4: Lists of cell-cycle periodic genes and their phases (in radians)
were downloaded from the supplementary materials of Whitfield et al.(Whitfield et al.
2002) and Grant et al.(Grant et al. 2013). Domain positions for “S” and “M” phases of the
cell-cycle were derived by computing the phase vector-average angle for the
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representative gene sets “KEGG_DNA_REPLICATION” and
“REACTOME_MITOTIC_PROMETAPHASE,” respectively. Positions for “G1” and “G2”
were then superimposed onto the midway points between “S” and “M” positions.
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CHAPTER 4:
CLOSING REMARKS

A foundation for the building and interpretation of a comprehensive atlas of the
mammalian circadian transcriptome has been presented here. To characterize the role
of the circadian clock in mouse physiology and behavior, we used RNA-seq and DNA
arrays to quantify the transcriptomes of twelve mouse organs over time. We found 43%
of all protein coding genes showed circadian rhythms in transcription somewhere in the
body, largely in an organ-specific manner. In most organs, we noticed the expression of
many oscillating genes peaked during transcriptional “rush hours” preceding dawn and
dusk. Looking at the genomic landscape of rhythmic genes, we saw that they clustered
together, were longer, and had more spliceforms than non-oscillating genes. Systemslevel analysis revealed intricate rhythmic orchestration of gene pathways throughout the
body. We also found oscillations in the expression of more than one thousand known
and novel non-coding RNAs (ncRNAs). Supporting their potential role in mediating clock
function, ncRNAs conserved between mouse and human showed rhythmic expression in
similar proportions as protein coding genes. Importantly, we also found that the majority
of best-selling drugs and World Health Organization essential medicines directly target
the products of rhythmic genes. Many of these drugs have short half-lives and may
benefit from timed dosage. In sum, this study highlights critical, systemic, and surprising
roles of the mammalian circadian clock and provides a blueprint for advancement in
chronotherapy.
77	
  
	
  

A computational algorithm to discover gene-phase set enrichment in circadian
data was also developed. This algorithm overcomes shortcomings of existing gene-set
enrichment analysis tools that do not allow the handling of data from a cyclic domain.
Applying the algorithm to several in-house and published datasets, we find that activity
of many biological pathways comprised of circadian genes cluster temporally.
Importantly, clustering often occurred at critical times of the day, such as dawn, which
were missed by existing analysis methods. We also found that restricted feed time leads
to complete phase-shifts in physiology, while restricted sleep time does not. Restriction
of feed time appeared to disrupt coupling between timing of degradation and synthesis
processes. Separately, we discovered that circadian genes uniquely bound to by the
core clock factor, CLOCK, cluster in phase whereas those for other core clock factors do
not. Finally, we showed that gene-phase set enrichment could be easily adapted to
analyze cell-cycle data.

Future directions
The atlas of the mammalian circadian transcriptome that we have generated is
an enormous dataset that captures biological space and time of the mouse at a very
high resolution. The results presented in this dissertation scratch the surface of what can
be gleamed from this data, but there is enough data to power perhaps hundreds of
future studies. Currently, we have catalogued twelve organs, but we would eventually
like to catalogue every organ and tissue in the body. Work on cataloguing the SCN is
currently underway in our lab at the time of this writing.
78	
  
	
  

Aside from cataloguing more and more organs, it is also natural to imagine the
cataloguing of many other species. Drosophila, Arabidopsis, zebrafish and worm are
popular model organisms that come to mind. Due to invasiveness of current RNA
collection methods, humans are unsuitable subjects at this time but remain the ultimate
future goal. Our hope is also that technology will one day advance to the point where
proteins can also be quantified with the level of ease and accuracy as is possible for
DNA and RNA today.
Our findings regarding widespread targeting of circadian genes by blockbuster
drugs obviously point in a hugely impactful future direction. Here, we have essentially
performed an initial screen for noteworthy drugs that may benefit from time-of-day based
dosing, but clinical trials examining efficacy and toxicity dependent on time of
administration for individual drugs will be required to ascertain the optimal dosing
schedule for any given treatment. It will be important to examine time as an independent
variable at all stages of future clinical trials.
In phase 0, where the aim is to characterize pharmacokinetics and
pharmacodynamics using sub-therapeutic doses, trials must systematically distinguish
absorption, distribution, metabolization, excretion, and interactions of drugs within the
body at multiple circadian time points over the course of multiple circadian cycles (days)
in order to establish adequate temporal profiling. Similarly, in phase 1, where the aim is
to determine dose safety, the drug in question must be administered to different groups
of subjects at different time points of the day and side effects monitored independently
for each group. In phase 2, the aim is to establish efficacy of a drug, and here the drug in
question must again be administered to different groups of subjects at different time
points of the day with efficacy evaluated independently for each group. Finally, during
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phase 3 and eventually phase 4, data must be stratified systematically by circadian time
in order to formulate guidelines for proper temporal dosing. Awareness of circadian
rhythm effects on clinical diagnosis and treatment will likely increase by much in the
coming years as more work along these lines is reported.

Final thoughts
The study of circadian rhythms is a field currently experiencing explosive growth.
Though we feel that the work presented here is highly impactful at this stage, there is no
doubt that it is but a small piece to a much larger story than could be captured by any
one, or even multiple, dissertations. The author’s intent is that the findings and
methodologies described here may catalyze continued research interest in this area,
especially towards the improvement of clinical practice in the real world.
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APPENDIX

To conserve manuscript space, lengthier data produced from this work have
been collected as supplementary digital files. Below are legends for these datasets.

Supplementary_dataset_S1.xls:
Dataset S1. Drugs from the top-100 best-selling drugs list that target circadian genes.
Extended and verbose version of Table 2.1. All drugs from the top-100 best-selling drugs
list are recorded, regardless of half-life.

Supplementary_dataset_S2.xls:
Dataset S2. Drugs from the WHO Essential Medicines list that target circadian genes.
As Dataset S1 except for drugs listed under the World Health Organization’s official list
of essential medicines.

Supplementary_dataset_S3.xls:
Dataset S3. Half-life notes on all drugs from Datasets S1 and S2.

Supplementary_dataset_S4.xls:
Dataset S4: Oscillation phases of all conserved, non-coding RNAs.
Annotation data includes genomic coordinates from the mouse genome, the assigned
RefSeq IDs and gene symbols from mouse and human, the direction of the alignment
between the ncRNA and RefSeq sequences (sense or antisense), and the functional
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group assigned to each ncRNA. Additionally, this file lists the peak phase in expression
for each tissue, as well as the number of tissues in which each ncRNA oscillates.

Supplementary_dataset_S5.xls:
Dataset S5. Antisense transcripts.
Annotation data includes the genomic coordinates for each transcript, as well as the
Ensembl gene ID and symbol for the overlapping sense transcript. Additionally, this file
lists the difference between peak expression phase in the sense and antisense
transcripts for each tissue. If these columns list "antisense_osc_only", or
"sense_osc_only", it means that in the given tissue, only the antisense or sense
transcript oscillated, respectively. Lastly, this file contains four summary columns that list
the number of tissues in which the antisense transcript oscillated, the number in which
the sense transcript oscillated, the number in which both oscillated, and the maximum
difference in peak expression phase across all tissues.
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